Literature DB >> 737287

Solution conformation of peptides by the intramolecular nuclear Overhauser effect experiment. Study of valinomycin-K+.

N R Krishna, D G Agresti, J D Glickson, R Walter.   

Abstract

This study demonstrates how the intramolecular nuclear Overhauser effect (NOE) experiment can be employed quantitatively to select from a set of possible conformations for a peptide or a protein the particular conformation (or a group of conformations) most consistent with the data. This procedure is demonstrated on a model depsipeptide system--valinomycin K+ in CDCl3--for which the solution conformation has been inferred by other methods. The NOE enhancements are very sensitive to the conformations assumed by this antibiotic. It is shown that the set of conformations, collectively labeled as A2 (including the X-ray crystallographic structure) gives a very good description of the NOE enhancements. The structure proposed by Bystrov et al. (1977. Eur. J. Biochem. 78:63) for the uncomplexed valinomycin in nonpolar solvents is also consistent with the experimental data on the potassium complex. Using statistical hypothesis testing involving the Hamilton R-factor ratio criterion, all the other models have been rejected as inconsistent with the experimental data. A general formalism is presented for describing the NOE effects in isotropically reorienting molecules. The formalism is not restricted to the extreme narrowing limit of the rotational correlation times and hence applies to both small and large molecules. Some of the factors that can influence the NOE measurements, viz. anisotropic rotational diffusion, conformational averaging, and nuclear spin diffusion, have been considered in this study.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 737287      PMCID: PMC1473485          DOI: 10.1016/S0006-3495(78)85421-6

Source DB:  PubMed          Journal:  Biophys J        ISSN: 0006-3495            Impact factor:   4.033


  25 in total

1.  Nuclear Overhauser enhancement demonstration of the type II beta-turn in repeat peptides of tropoelastin.

Authors:  M A Khaled; D W Urry
Journal:  Biochem Biophys Res Commun       Date:  1976-05-17       Impact factor: 3.575

2.  Lanthanide induced NMR perturbations of HEW lysozyme: evidence for nonaxial symmetry.

Authors:  D G Agresti; R E Lenkinski; J D Glickson
Journal:  Biochem Biophys Res Commun       Date:  1977-06-06       Impact factor: 3.575

3.  Refinement of the solution conformation of valinomycin with the acid coupling constants from the 13C-nuclear-magnetic-resonance spectra.

Authors:  V F Bystrov; Y D Gavrilov; V T Ivanov; Y A Ovchinnikov
Journal:  Eur J Biochem       Date:  1977-08-15

4.  Raman spectroscopy of uncomplexed valinomycin. I. The solid state.

Authors:  I M Asher; K J Rothschild; E Anastassakis; H E Stanley
Journal:  J Am Chem Soc       Date:  1977-03-30       Impact factor: 15.419

5.  Solvent-dependent conformations of valinomycin in solution.

Authors:  D J Patel; A E Tonelli
Journal:  Biochemistry       Date:  1973-01-30       Impact factor: 3.162

6.  Use of proton nuclear Overhauser effects for the determination of the conformations of amino acid residues in oligopeptides.

Authors:  S J Leach; G Némethy; H A Scheraga
Journal:  Biochem Biophys Res Commun       Date:  1977-03-07       Impact factor: 3.575

7.  Nuclear Overhauser effects and the conformation of gramicidin S.

Authors:  I D Rae; E R Stimson; H A Scheraga
Journal:  Biochem Biophys Res Commun       Date:  1977-07-11       Impact factor: 3.575

8.  Nuclear Overhauser enhancement evidence for inverse temperature dependence of hydrophobic side chain proximity in the polytetrapeptide of tropoelastin.

Authors:  D W Urry; M A Khaled; R S Rapaka; K Okamoto
Journal:  Biochem Biophys Res Commun       Date:  1977-12-07       Impact factor: 3.575

9.  Intramolecular 1H nuclear Overhauser effect study of the solution conformation of valinomycin in dimethyl sulfoxide.

Authors:  J D Glickson; S L Gordon; P Pitner; D G Agresti; R Walter
Journal:  Biochemistry       Date:  1976-12-28       Impact factor: 3.162

10.  Fluorotyrosine alkaline phosphatase from Escherichia coli: preparation, properties, and fluorine-19 nuclear magnetic resonance spectrum.

Authors:  B D Sykes; H I Weingarten; M J Schlesinger
Journal:  Proc Natl Acad Sci U S A       Date:  1974-02       Impact factor: 11.205

View more
  6 in total

1.  Solution conformation of gramicidin S: An intramolecular nuclear Overhauser effect study.

Authors:  D H Huang; R Walter; J D Glickson; N R Krishna
Journal:  Proc Natl Acad Sci U S A       Date:  1981-02       Impact factor: 11.205

2.  Identification of the binding site of an allosteric ligand using STD-NMR, docking, and CORCEMA-ST calculations.

Authors:  Wei Zhang; Rongbao Li; Ronald Shin; Yimin Wang; Indira Padmalayam; Ling Zhai; N Rama Krishna
Journal:  ChemMedChem       Date:  2013-07-25       Impact factor: 3.466

3.  A variable target intensity-restrained global optimization (VARTIGO) procedure for determining three-dimensional structures of polypeptides from NOESY data: application to gramicidin-S.

Authors:  Y Xu; I P Sugár; N R Krishna
Journal:  J Biomol NMR       Date:  1995-01       Impact factor: 2.835

4.  CORCEMA evaluation of the potential role of intermolecular transferred NOESY in the characterization of ligand-receptor complexes.

Authors:  E V Curto; H N Moseley; N R Krishna
Journal:  J Comput Aided Mol Des       Date:  1996-10       Impact factor: 3.686

5.  Conformational Changes in Tyrosine 11 of Neurotensin Are Required to Activate the Neurotensin Receptor 1.

Authors:  Fabian Bumbak; Trayder Thomas; Billy J Noonan-Williams; Tasneem M Vaid; Fei Yan; Alice R Whitehead; Shoni Bruell; Martina Kocan; Xuan Tan; Margaret A Johnson; Ross A D Bathgate; David K Chalmers; Paul R Gooley; Daniel J Scott
Journal:  ACS Pharmacol Transl Sci       Date:  2020-04-29

6.  A STD-NMR study of the interaction of the Anabaena ferredoxin-NADP+ reductase with the coenzyme.

Authors:  Lara V Antonini; José R Peregrina; Jesús Angulo; Milagros Medina; Pedro M Nieto
Journal:  Molecules       Date:  2014-01-07       Impact factor: 4.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.